Intercept: OCA-Bezafibrate Combo Data In PBC At EASL 2024
05 Jun 2024 //
GLOBENEWSWIRE
Intercept Shows OCA-Bezafibrate Combo Impact On ALP, Metabolic Outcomes
18 May 2024 //
GLOBENEWSWIRE
Intercept Announces Phase 2 Data Showing Significant Impact of OCA-Bezafibrate
13 Nov 2023 //
GLOBENEWSWIRE
Intercept Presents New Data Showing Significant Impact of OCA-bezafibrate
23 Jun 2023 //
GLOBENEWSWIRE
Intercept Announces New Data Showing Potential of Fixed-Dose Combination of OCA
07 Jun 2023 //
GLOBENEWSWIRE
Intercept Announces First Patient Dosed in Phase 2 Study of OCA and Bezafibrate
11 May 2022 //
GLOBENEWSWIRE
Intercept’s Phase II-ready Ocaliva/bezafibrate has mixed experts views
11 Dec 2019 //
CLINICALTRIALSARENA
Anvisa Suspends the Import of All Pharmaceutical Raw Materials from Sinbiotik SA, Mexico
09 Apr 2015 //
ANVISA